biotech · Ataxia Telangiectasia · Ataxia Telangiectasia (A-T) · QNCX
Quince Therapeutics
Quince Therapeutics patent portfolio — 1 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.
South San Francisco, USA HQ
2012 Founded
21 Employees
Public company Type
QNCX · NYSE Ticker
Company details
- Status
- Public
- HQ
- South San Francisco, USA
- Founded
- 2012
- Employees
- 21
- Programs
- 10
- Drugs
- 8
- Patents
- 1
Quince Therapeutics patents
1 pharmaceutical patents indexed for Quince Therapeutics. 0 expire within 24 months.
Quince Therapeutics has 1 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months — use filters for patent-cliff planning.
Patent portfolio
Frequently asked questions
How many patents does Quince Therapeutics have?
1 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).
When do Quince Therapeutics patents expire?
0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.